Mohamed Alsharedi

6PUBLICATIONS
2CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursPredictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 28, 2019
Immune Checkpoint Inhibitors in Locally Advanced, Unresectable, and Metastatic Upper Gastrointestinal Malignancies.

Heather Katz, Layana Biglow, Mohamed Alsharedi

|Feb 21, 2019
Long-term direct oral anticoagulation in primary osteonecrosis with elevated plasminogen activation inhibitor.

Maria Monica Haydock, Shahed Elhamdani, Mohamed Alsharedi

|Dec 05, 2018
Solitary Lytic Bone Metastasis: A Rare Presentation of Small Lymphocytic Leukemia.

Heather Katz, Steven Sagun, Doreen Griswold

|Dec 20, 2017
Immunotherapy in triple-negative breast cancer.

Heather Katz, Mohamed Alsharedi

|Sep 03, 2017
Checkpoint inhibitors: the new treatment paradigm for urothelial bladder cancer.

Heather Katz, Emnet Wassie, Mohamed Alsharedi

|Feb 18, 2016
Comparison of toxicity profile and tolerability between two standard of care paclitaxel-based adjuvant chemotherapy regimens in breast cancer.

Mohamed Alsharedi, Todd Gress, Jennifer Dotson

Pageof 1